is the functional protein product of the CDKN2A gene. High expression can induce cell cycle arrest and senescence. New evidence suggests that senescent GBM cells may recruit T cells by releasing chemokines such as CCL13, shaping an immunogenic tumor microenvironment and potentially improving patient prognosis. This evidence concerns the gene CDKN2A and glioblastoma.